Apart from conversion of glutamate to α-ketoglutarate using glutamate dehydrogenase 1 (GLUD1), cancer cells utilize glutamic-oxaloacetic transaminase 1 (GOT1) to generate oxaloacetate from glutamine-derived aspartate. Here, GLUD1 is linked to cancer.